Nanolive will be present at the ASCB|EMBO meeting this year in Washington D.C., from the 3rd to the 7th of December, where we’ll be showcasing our vast range of label-free high content phenotypic solutions, that combine screening, imaging, and analysis to radically advance the study of living cells and provide novel biological insights.
If you are attending the meeting, don’t miss the opportunity to visit our team at booth #2225, to book your demo or to get more information on the latest tools to accelerate your drug discovery and to help you getting higher significance, earlier and faster!
Tech Talk
Join us for a tech talk “Nanolive: A Label-free High Content Phenotypic Solution for De-risking Drug Discovery and Development for Immuno-oncology, Cell Metabolism and Cytotoxicity Studies” on December 5th from 3.15 to 4.00pm, in Theater 1, presented by our US General Manager Jonathan Day and Scientific Communication Specialist Hope Amos.
Read our latest news
Newsletter March: AI-powered image analysis for quantifying mitochondrial dynamics
Welcome to the March edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live cell...
Nanolive launches the Smart Mitochondrial Assay LIVE
Nanolive launches another ground-breaking tool in cell analysis: the Smart Mitochondrial AssayLIVE, the world’s first fully automated solution for noninvasive, quantitative assessment of mitochondrial dynamics. Created to accelerate drug discovery, the Smart...
Newsletter February: Unlocking the power of Nanolive’s holotomography
Welcome to the February edition of the AI for Live Cell Insights Newsletter, bringing you the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...